daunorubicin hydrochloride for injection poudre pour solution
teva canada limited - daunorubicine (chlorhydrate de daunorubicine) - poudre pour solution - 20mg - daunorubicine (chlorhydrate de daunorubicine) 20mg - antineoplastic agents
daunorubicina 20 mg polvo para solucion inyectable
perulab s.a. - clorhidrato de daunorubicina; - polvo para solucion inyectable - por vial ; clorhidrato de daunorubicina 21.400000 mg; - daunorubicina
daunorubicin 20mg powder for i.v. injection
cherubino limited delf building, sliema road, gzira, gzr 1637, malta - daunorubicin - powder for injection - daunorubicin 20 mg - antineoplastic agents
daunorubicin r.p.
aventis pharma deutschland gmbh (8033602) - daunorubicinhydrochlorid - trockensubstanz - teil 1 - trockensubstanz; daunorubicinhydrochlorid (07163) 21,4 milligramm
daunorubicin
daunorubicin -
solution injectable de daunorubicine
generic medical partners inc - daunorubicine (chlorhydrate de daunorubicine) - solution - 20mg - daunorubicine (chlorhydrate de daunorubicine) 20mg - antineoplastic agents
solution injectable de daunorubicine
generic medical partners inc - daunorubicine (chlorhydrate de daunorubicine) - solution - 50mg - daunorubicine (chlorhydrate de daunorubicine) 50mg - antineoplastic agents
chlorhydrate de daunorubicine injectable solution
hikma canada limited - daunorubicine (chlorhydrate de daunorubicine) - solution - 20mg - daunorubicine (chlorhydrate de daunorubicine) 20mg
ondansetron 2mg/ml solution for injection
noridem enterprises limited - ondansetron - solution for injection - 2 milligram(s)/millilitre - serotonin (5ht3) antagonists; ondansetron
zofran injection 2mgml
novartis israel ltd - ondansetron as hydrochloride dihydrate - solution for injection - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ≥6 months, and for the prevention and treatment of ponv in children aged ≥ 1 month.